HLA-C and neoplasm: In addition, epigenetic drugs can induce tumor immunogenic cell death, upregulate various tumor-associated antigens and MHC molecules, and elicit generation of antigen-presenting cells (APCs), leading to enhancement of immune cell priming and effector T cell recognition of tumor cells [9–11].